We would like to congratulate portfolio company Baebies on their new partnership with CureDuchenne.
Baebies is delivering innovative products and services for newborn screening and pediatric testing. As part of the deal, Baebies will add Duchenne muscular dystrophy, the most common and lethal form of muscular dystrophy that primarily affects young boys, to its expanded newborn screening service.
You can read more about it here.